Lv6
2770 积分 2024-07-09 加入
Chinese Position Paper on Biologic Therapy for Allergic Rhinitis
2个月前
已完结
Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial
2个月前
已完结
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
2个月前
已完结
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
2个月前
已完结
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
2个月前
已完结
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
2个月前
已完结
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
2个月前
已完结
Erenumab: A novel calcitonin gene-related peptide receptor antagonist developed specifically for migraine prevention
2个月前
已完结
Erenumab: First Global Approval
2个月前
已完结
PACAP pathway: a new frontier in migraine prevention
2个月前
已完结
皖公网安备34019202002308
